UBS Group’s Immatics N.V. Warrants IMTXW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-312
| Closed | – | – | 10585 |
|
|
2025
Q2 | $0 | Sell |
312
-2,385
| -88% | -$37 | ﹤0.01% | 10531 |
|
|
2025
Q1 | $43 | Buy |
2,697
+2,555
| +1,799% | +$136 | ﹤0.01% | 10029 |
|
|
2024
Q4 | $36 | Buy |
+142
| New | +$118 | ﹤0.01% | 9734 |
|
|
2024
Q3 | – | Sell |
-83
| Closed | -$230 | – | 9767 |
|
|
2024
Q2 | $230 | Hold |
83
| – | – | ﹤0.01% | 9054 |
|
|
2024
Q1 | $224 | Buy |
+83
| New | +$287 | ﹤0.01% | 8719 |
|
|
2022
Q4 | – | Sell |
-232
| Closed | -$1K | – | 10913 |
|
|
2022
Q3 | $1K | Buy |
+232
| New | +$725 | ﹤0.01% | 9968 |
|
|
2022
Q2 | – | Sell |
-1,098
| Closed | -$2K | – | 10603 |
|
|
2022
Q1 | $2K | Buy |
+1,098
| New | +$2.53K | ﹤0.01% | 9640 |
|
|
2021
Q3 | – | Sell |
-508
| Closed | -$2K | – | 9787 |
|
|
2021
Q2 | $2K | Buy |
+508
| New | +$1.69K | ﹤0.01% | 8953 |
|
|
2021
Q1 | – | Sell |
-2,260
| Closed | -$7K | – | 9223 |
|
|
2020
Q4 | $7K | Sell |
2,260
-208
| -8% | -$596 | ﹤0.01% | 7691 |
|
|
2020
Q3 | $9K | Buy |
+2,468
| New | +$8.24K | ﹤0.01% | 6932 |
|
UBS Group's IMTXW Position: Q3 2025 in Review
UBS Group sold out of Immatics N.V. Warrants (IMTXW) in Q3 2025, closing a stake of 312 shares.
UBS Group first reported a position in IMTXW in Q3 2020 and held it in 10 quarters. The position peaked at $9K in Q3 2020. 0 funds tracked by Wall St. Rank hold IMTXW as of Q3 2025.
- UBS Group reported no remaining Immatics N.V. Warrants position as of Q3 2025 after selling out during the quarter.
- UBS Group sold 312 Immatics N.V. Warrants shares in Q3 2025.
- UBS Group first reported a position in Immatics N.V. Warrants in Q3 2020 and held it in 10 quarters.
- UBS Group's Immatics N.V. Warrants position peaked at $9K in Q3 2020.
- 0 funds tracked by Wall St. Rank held Immatics N.V. Warrants as of Q3 2025.
Based on UBS Group's 13F filing for Q3 2025, filed 13 Nov 2025.